Start Date
April 30, 2002
Primary Completion Date
February 28, 2007
ziv-aflibercept
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH
Regeneron Pharmaceuticals
INDUSTRY